Training to reduce the effects of alcohol on HIV infection

Translational Science Training to Reduce the Impact of Alcohol on HIV Infection

NIH-funded research University of Florida · NIH-10904730

This study is all about training new researchers to understand how drinking alcohol affects people with HIV, so they can work together to find better ways to help those living with the virus.

Quick facts

Grant typeTraining grant
Study typeNIH-funded research
Funding institutionUniversity of Florida NIH-funded
Lab location1 site (Gainesville, United States)
Project IDNIH-10904730 on NIH RePORTER

What this research studies

This program focuses on training predoctoral and postdoctoral fellows to understand and address the impact of alcohol consumption on HIV infection and related health outcomes. It aims to create an interdisciplinary research team skilled in health behavior intervention, epidemiology, and cognitive science to tackle the challenges of HIV transmission exacerbated by alcohol use. Trainees will receive mentorship, develop leadership skills, and learn to communicate their findings effectively, all while adhering to ethical research practices.

Who could benefit from this research

Good fit: Ideal candidates for this research are individuals in Florida who are affected by HIV and may also struggle with alcohol use or related health issues.

Not a fit: Patients who do not have HIV or are not affected by alcohol use may not receive direct benefits from this research.

Why it matters

Potential benefit: If successful, this research could lead to improved strategies for reducing HIV transmission and enhancing health outcomes for individuals affected by both alcohol use and HIV.

How similar studies have performed: Previous research has shown that interdisciplinary approaches to addressing the intersection of alcohol use and HIV can lead to meaningful advancements in treatment and prevention strategies.

Where this research is happening

Gainesville, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions HIV InfectionsHTLV-III InfectionsHTLV-III-LAV InfectionsHuman T-Lymphotropic Virus Type III Infections
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.